首页> 外文OA文献 >Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study

【2h】

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study

机译：罗非昔布和延长恒定输注吉西他滨在晚期非小细胞肺癌中的因子III期随机试验：GEccitabine-COxib在NsCLC（GECO）研究中的应用。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Cesare Gridelli; Ciro Gallo; Anna Ceribelli; Vittorio Gebbia; Teresa Gamucci; Fortunato Ciardiello; Francesco Carozza; Adolfo Favaretto; Bruno Daniele; Domenico Galetta; Santi Barbera; Francesco Rosetti; Antonio Rossi; Paolo Maione; Francesco Cognetti; Antonio Testa; Massimo Di Maio; Alessandro Morabito; Francesco Perrone;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study. [J] . Gridelli C, Gallo C, Ceribelli A, The lancet oncology . 2007,第6期

机译：罗非考昔的因子三期随机试验和吉西他滨长期持续输注在晚期非小细胞肺癌中的应用：NSCLC中的吉西他滨-COxib（GECO）研究。
2. Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial. [J] . Grigorescu AC, Draghici IN, Nitipir C, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2002,第1期

机译：吉西他滨（GEM）和卡铂（CBDCA）与顺铂（CDDP）和长春碱（VLB）在晚期非小细胞肺癌（NSCLC）的III和IV期：III期随机试验。
3. Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group [J] . ? Fl?tten, B H Gr?nberg, R Bremnes, British Journal of Cancer . 2012,第3期

机译：长春瑞滨和吉西他滨与长春瑞滨和卡铂作为晚期NSCLC的一线治疗。挪威肺癌研究小组进行的III期随机对照试验
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group [O] . Ø Fløtten, B H Grønberg, R Bremnes, 2012

机译：长春瑞滨和吉西他滨与长春瑞滨和卡铂作为晚期NSCLC的一线治疗。挪威肺癌研究小组进行的III期随机对照试验
6. Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101) [O] . Comella P, Filippelli G, De Cataldis G, 2007

机译：顺铂联合吉西他滨和长春瑞滨或吉西他滨和紫杉醇联合治疗局部晚期或转移性非小细胞肺癌的疗效：意大利南部合作肿瘤小组（SICOG 0101）的一项III期随机试验

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study

著录项

引文网络

相似文献

相关主题

期刊订阅